Trials / Terminated
TerminatedNCT02615522
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
Prospektive, Klinische Verlaufsuntersuchung (Post Market Follow-Up) Der primären Knieendoprothese BPK-S Integration
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 124 (actual)
- Sponsor
- Peter Brehm GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, monocenter post market clinical follow-up of a primary knee replacement bearing the CE-mark. 200 subjects will be recruited and followed up for up to ten years or until revision of the primary knee endoprosthesis, whichever occurs first. Documentation of clinical and radiological parameters within the clinical routine pre-operative and post-operative at 3 and 12 months and 2, 5 and 10 years to evaluate time to revision, pain situation, knee functionality, mobility and stability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BPK-S Integration |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2015-11-26
- Last updated
- 2022-04-20
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02615522. Inclusion in this directory is not an endorsement.